LifeTech Scientific Stock

LifeTech Scientific ROE

The Return on Equity (ROE) of LifeTech Scientific (1302.HK) as of Aug 4, 2026 is 4.21 %. In the previous year, Return on Equity (ROE) was 5.48 % — a change of -23.27% (lower).

ROE

4.21 %

YoY

-23.27%

Last updated:

In 2026, LifeTech Scientific's return on equity (ROE) was 4.21 %, a -23.27% increase from the 5.48 % ROE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

ROE Details

Decoding LifeTech Scientific's Return on Equity (ROE)

LifeTech Scientific's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing LifeTech Scientific's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

LifeTech Scientific's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in LifeTech Scientific’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about LifeTech Scientific stock

Return on Equity (ROE) of LifeTech Scientific is 4.21 % in 2026.

Return on Equity (ROE) of LifeTech Scientific changed from 5.48 % to 4.21 %, representing a -23.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s LifeTech Scientific with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — LifeTech Scientific

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — LifeTech Scientific